N-deacetylated BMS-202 is the deacetylated of BMS-202.

N-deacetylated BMS-202 inhibits PD-1/PD-Ll interaction, and may augment therapeutic immune response to a number of histologically distinct tumors. Blockade of the PD-1/PD-Ll ligation using antibodies to PD-Ll has been shown to restore and augment T cell activation in many systems[1].

2310135-18-1

C23H27N3O2

377.48

N-deacetylated BMS-202

DMSO:36 mg/mL (95.37 mM)
Powder: -20°C for 3 years
In solvent: -80°C for 2 years